IonQ, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. This is an annual report; the supplied filing text does not provide standalone fourth-quarter results. Comparisons below are with FY2022.
Business context
IonQ develops trapped-ion quantum computers and sells specialized hardware, quantum-computing-as-a-service (QCaaS), and related support and consulting. Customers can access its systems through AWS Amazon Braket, Microsoft Azure Quantum, Google Cloud Marketplace, and IonQ’s own cloud service. The company remains at an early commercial stage and has not achieved broad quantum advantage or produced a scalable quantum computer.
Financial results and liquidity
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Revenue | $22.0 million | $11.1 million | +98% |
| Operating expenses | $179.8 million | $96.9 million | +86% |
| Operating loss | $(157.8) million | $(85.7) million | Loss widened |
| Net loss | $(157.8) million | $(48.5) million | Loss widened |
| Basic and diluted loss per share | $(0.78) | $(0.25) | — |
| Cash used in operating activities | $(78.8) million | $(44.7) million | Use increased |
Revenue growth reflected progress on specialized hardware arrangements and new service contracts. R&D rose 110% to $92.3 million, primarily due to payroll and stock-based compensation; sales and marketing rose 118% to $18.3 million, and general and administrative expense rose 41% to $50.7 million. Total stock-based compensation was $74.4 million, including $69.7 million recognized in operating expenses.
Cost of revenue, excluding depreciation and amortization, was $8.1 million. Revenue less this cost was $13.9 million, or approximately 63% of revenue, before depreciation and amortization; this is not a fully burdened gross margin. Interest income was $19.3 million, up from $7.1 million. A $19.2 million loss from changes in warrant fair value replaced a $30.1 million gain in FY2022 and materially affected the year-over-year net-loss comparison.
At December 31, 2023, cash, cash equivalents and available-for-sale investments totaled $455.9 million; restricted cash of $2.4 million was excluded from that amount. Management said available liquidity should cover working capital and capital expenditures for at least the next 12 months, subject to changing business and market conditions. Investing activities provided $68.8 million, primarily reflecting net investment maturities; financing activities provided $1.8 million, mainly from option exercises.
Total assets were $553.6 million and total liabilities were $68.6 million. The filing reports no conventional borrowings in the supplied balance-sheet data; liabilities included $23.0 million of warrant liabilities and $8.1 million of operating lease liabilities. Operating lease commitments totaled $19.8 million, with $1.9 million payable within 12 months, according to the liquidity discussion. Accumulated deficit was $352.1 million.
Material changes and other key facts
- Revenue nearly doubled, but operating cash use rose by $34.1 million and net loss increased substantially.
- Two customers represented 58% of FY2023 revenue, compared with three customers representing 70% in FY2022. Revenue concentration remains material.
- Remaining performance obligations were approximately $69.1 million at year-end, including funded and unfunded orders; IonQ expected about 40% to be recognized within 12 months.
- Headcount reached 324 employees at December 31, 2023. IonQ became a large accelerated filer and ceased to qualify as an emerging growth company at year-end, increasing reporting requirements.
- Auditor EY issued unqualified opinions on the financial statements and internal control over financial reporting. The auditor identified capitalization of internal-use software costs as a critical audit matter; $8.0 million of such costs were capitalized in FY2023.
Outlook, risks and contingencies
IonQ expects significant losses and higher operating expenses for the foreseeable future as it funds research, product development, manufacturing capability and commercialization. It identifies cash, cash equivalents and investments as its principal liquidity sources and may seek additional equity, debt or collaboration financing. The filing does not provide a clear numerical FY2024 revenue or earnings forecast in the supplied text.
Key risks include failure or delay in achieving technical milestones and quantum advantage; inability to scale manufacturing or reduce costs; competition and rapid technological change; reliance on cloud-platform partners and limited suppliers of isotopically enriched materials; customer and government-contract concentration, long sales cycles and funding uncertainty; and the possibility of needing additional capital. IonQ also cites cybersecurity, international, export-control, privacy, intellectual-property and regulatory risks. It reported past cybersecurity incidents but said none had materially affected the company or its financial position, results or cash flows.
A consolidated securities class action was dismissed with prejudice in September 2023, but plaintiffs filed a post-judgment motion seeking to amend the complaint; IonQ said it could not reasonably estimate any possible loss. A separate dMY-related case was considered closed after claims against the former registrant were dismissed during 2023. Inflation and higher interest rates were noted as potential cost and financing pressures; IonQ said inflation had not materially affected results to date.
Important facts for investors to verify
- Whether revenue growth and the $69.1 million remaining-performance-obligation balance convert into collected cash and recurring customer demand.
- Customer concentration, contract funding status, timing, cancellation rights and related-party revenue; UMD-related revenue was $4.6 million in FY2023.
- Progress against technical and manufacturing milestones, including system scalability, fidelity, gate speed and photonic interconnect development.
- Cash burn, investment liquidity, capital-expenditure plans and the assumptions behind management’s stated 12-month liquidity coverage.
- Effects of stock-based compensation, warrant remeasurement and potential dilution from outstanding equity awards and warrants.
- Status and potential financial impact of the plaintiffs’ post-judgment motion in the securities litigation.